Zhejiang Jingxin Pharmaceutical Co Ltd (002020):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhejiang Jingxin Pharmaceutical Co Ltd (002020) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7620
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhejiang Jingxin Pharmaceutical Co Ltd (Jingxin Pharma) is a pharmaceutical company that manufactures and markets traditional Chinese medicine. The company provides products such as finished dosage forms, Chinese herbal drugs and APIs. Its finished dosage products comprise simvastatin tablets, lovastatin capsules, fenofibrate capsules, gliclazid tablets, cilnidipine capsules, sertraline hydrochloride dispersing tablets, sertraline hydrochloride tablets, cisapride tablets, and ciprofloxacin hydrochloride capsules. Jingxin Pharma offers API products such as simvastatin, levofloxacin hemihydrate, ciprofloxacin hydrochloride, levofloxacin lactate, ofloxacin, enrofloxacin base, enrofloxaxin hydrochloride, ciprofloxacin lactate, and rosuvastatin calcium, among others. The company’s Chinese herbal drugs include coptis bolus ,mind-easing tonic, leucorrhea pill, sexoton pill, and menstruation-regulating bolus, and bolus for indigestion, among others. It offers its products in the dosage forms of tablets, capsules, large volume injections and powder for injections. Jingxin Pharma is headquartered in Shaoxing, China.

Zhejiang Jingxin Pharmaceutical Co Ltd (002020) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jingxin Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Zhejiang Jingxin Pharma and HYZ Healthcare Forms Joint Venture 12
Equity Offering 13
Zhejiang Jingxin Pharma Raises USD158.3 Million in Private Placement Shares 13
Mapi Pharma to Raise USD10 Million in Private Placement of Shares 14
Zhejiang Jingxin Pharma Announces Private Placement Of Shares For US$82 Million 15
Acquisition 16
Zhejiang Jingxin Pharma to Acquire 25% Stake in Spes Pharma for USD2 Million 16
Zhejiang Jingxin Pharma Plans to Acquire Additional 6.2% Stake in Pharmula Labs for USD0.5 Million 17
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 18
Zhejiang Jingxin Pharma to Acquire 51% Stake in Pharmula Labs 19
Zhejiang Jingxin Pharmaceutical Co Ltd – Key Competitors 20
Zhejiang Jingxin Pharmaceutical Co Ltd – Key Employees 21
Zhejiang Jingxin Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jingxin Pharmaceutical Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jingxin Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Zhejiang Jingxin Pharma and HYZ Healthcare Forms Joint Venture 12
Zhejiang Jingxin Pharma Raises USD158.3 Million in Private Placement Shares 13
Mapi Pharma to Raise USD10 Million in Private Placement of Shares 14
Zhejiang Jingxin Pharma Announces Private Placement Of Shares For US$82 Million 15
Zhejiang Jingxin Pharma to Acquire 25% Stake in Spes Pharma for USD2 Million 16
Zhejiang Jingxin Pharma Plans to Acquire Additional 6.2% Stake in Pharmula Labs for USD0.5 Million 17
Zhejiang Jingxin Pharma to Acquire Stake in Pharma Two B for USD5 Million 18
Zhejiang Jingxin Pharma to Acquire 51% Stake in Pharmula Labs 19
Zhejiang Jingxin Pharmaceutical Co Ltd, Key Competitors 20
Zhejiang Jingxin Pharmaceutical Co Ltd, Key Employees 21
Zhejiang Jingxin Pharmaceutical Co Ltd, Subsidiaries 22

List of Figures
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jingxin Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jingxin Pharmaceutical Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Zhejiang Jingxin Pharmaceutical Co Ltd (002020):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caspian Energy Inc. (CKZ.H)-石油・ガス分野:企業M&A・提携分析
    Summary Caspian Energy Inc. (Caspian) is an independent upstream oil and gas company that explores for and develops hydrocarbon reserves, and produces oil and gas. Caspian and its subsidiaries hold interests in Aral Petroleum Capital LLP, which holds an exclusive license which entitles it to explore …
  • Torii Pharmaceutical Co Ltd (4551)-製薬・医療分野:企業M&A・提携分析
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • Newfoundland Power Inc:企業の戦略的SWOT分析
    Newfoundland Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Great Southern Bancorp Inc:企業の戦略・SWOT・財務分析
    Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Great Southern Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Jadranka dd:企業の戦略・SWOT・財務分析
    Jadranka dd - Strategy, SWOT and Corporate Finance Report Summary Jadranka dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Tilaknagar Industries Ltd:企業の戦略・SWOT・財務分析
    Tilaknagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Tilaknagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Filtronic plc:企業の戦略・SWOT・財務分析
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Illumina, Inc.:企業の戦略・SWOT・財務情報
    Illumina, Inc. - Strategy, SWOT and Corporate Finance Report Summary Illumina, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Providence Service Corporation:戦略・SWOT・企業財務分析
    Providence Service Corporation - Strategy, SWOT and Corporate Finance Report Summary Providence Service Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Astron Corp Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corp Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • OHB System AG:企業の戦略・SWOT・財務情報
    OHB System AG - Strategy, SWOT and Corporate Finance Report Summary OHB System AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Centrais Eletricas do Para SA (CELP5):電力:M&Aディール及び事業提携情報
    Summary Centrais Eletricas do Para SA (CELPA), a subsidiary of Equatorial Energia SA is an electric utility that supplies and distributes power and electricity. The utility offers services such as electric metering, online bill payment, surge protection, outage reporting, energy saving tips, rebates …
  • Panasonic Corporation (6752):企業の財務・戦略的SWOT分析
    Panasonic Corporation (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Keio Corporation (9008):企業の財務・戦略的SWOT分析
    Keio Corporation (9008) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Stock Spirits Group PLC:企業の戦略・SWOT・財務情報
    Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report Summary Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Sucrerie Couplet SA:企業の戦略・SWOT・財務情報
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • BYD Co Ltd (1211):企業の財務・戦略的SWOT分析
    BYD Co Ltd (1211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務情報
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆